In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Axis Capital (AXS – Research Report), with a price target of $127.00. The company’s shares closed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator.

The latest SRAM RED AXS, which debuted in May 2024, took everything good about the prior Force & Rival updates, made it better, then took it further. Not only did the hood shapes improve like its ...

After hours: February 19 at 6:00:01 PM EST ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.